AKT1 and neoplasm: This study systematically reviews the molecular mechanisms by which NPs and TCM formulations inhibit VM formation across various tumor types, and summarizes multiple core intervention targets, including VE-cadherin, EphA2, MMPs, Twist1, HIF-1α, and PI3K/Akt.